These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
461 related articles for article (PubMed ID: 28599212)
1. Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress. Childs E; Lutz JA; de Wit H Drug Alcohol Depend; 2017 Aug; 177():136-144. PubMed ID: 28599212 [TBL] [Abstract][Full Text] [Related]
2. Effects of d-amphetamine upon psychosocial stress responses. Childs E; Bershad AK; de Wit H J Psychopharmacol; 2016 Jul; 30(7):608-15. PubMed ID: 27235381 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans. Wachtel SR; ElSohly MA; Ross SA; Ambre J; de Wit H Psychopharmacology (Berl); 2002 Jun; 161(4):331-9. PubMed ID: 12073159 [TBL] [Abstract][Full Text] [Related]
4. Effect of oral THC pretreatment on marijuana cue-induced responses in cannabis dependent volunteers. Lundahl LH; Greenwald MK Drug Alcohol Depend; 2015 Apr; 149():187-93. PubMed ID: 25725933 [TBL] [Abstract][Full Text] [Related]
5. Sex differences in the subjective effects of oral Δ Fogel JS; Kelly TH; Westgate PM; Lile JA Pharmacol Biochem Behav; 2017 Jan; 152():44-51. PubMed ID: 26780348 [TBL] [Abstract][Full Text] [Related]
7. Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users. Curran HV; Brignell C; Fletcher S; Middleton P; Henry J Psychopharmacology (Berl); 2002 Oct; 164(1):61-70. PubMed ID: 12373420 [TBL] [Abstract][Full Text] [Related]
8. The effect of high-dose dronabinol (oral THC) maintenance on cannabis self-administration. Schlienz NJ; Lee DC; Stitzer ML; Vandrey R Drug Alcohol Depend; 2018 Jun; 187():254-260. PubMed ID: 29689485 [TBL] [Abstract][Full Text] [Related]
9. Acute effects of oral delta-9-tetrahydrocannabinol (THC) on autonomic cardiac activity and their relation to subjective and anxiogenic effects. Pabon E; Rockwood F; Norman GJ; de Wit H Psychophysiology; 2022 Feb; 59(2):e13955. PubMed ID: 34665890 [TBL] [Abstract][Full Text] [Related]
10. Assessment of cognitive and psychomotor impairment, subjective effects, and blood THC concentrations following acute administration of oral and vaporized cannabis. Spindle TR; Martin EL; Grabenauer M; Woodward T; Milburn MA; Vandrey R J Psychopharmacol; 2021 Jul; 35(7):786-803. PubMed ID: 34049452 [TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users. Spindle TR; Cone EJ; Goffi E; Weerts EM; Mitchell JM; Winecker RE; Bigelow GE; Flegel RR; Vandrey R Drug Alcohol Depend; 2020 Jun; 211():107937. PubMed ID: 32247649 [TBL] [Abstract][Full Text] [Related]
12. Acute subjective effects after smoking joints containing up to 69 mg Δ9-tetrahydrocannabinol in recreational users: a randomized, crossover clinical trial. Hunault CC; Böcker KB; Stellato RK; Kenemans JL; de Vries I; Meulenbelt J Psychopharmacology (Berl); 2014 Dec; 231(24):4723-33. PubMed ID: 24879495 [TBL] [Abstract][Full Text] [Related]
13. Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis. Haney M; Malcolm RJ; Babalonis S; Nuzzo PA; Cooper ZD; Bedi G; Gray KM; McRae-Clark A; Lofwall MR; Sparenborg S; Walsh SL Neuropsychopharmacology; 2016 Jul; 41(8):1974-82. PubMed ID: 26708108 [TBL] [Abstract][Full Text] [Related]
14. Cannabis and creativity: highly potent cannabis impairs divergent thinking in regular cannabis users. Kowal MA; Hazekamp A; Colzato LS; van Steenbergen H; van der Wee NJ; Durieux J; Manai M; Hommel B Psychopharmacology (Berl); 2015 Mar; 232(6):1123-34. PubMed ID: 25288512 [TBL] [Abstract][Full Text] [Related]
15. An exploratory study of the combined effects of orally administered methylphenidate and delta-9-tetrahydrocannabinol (THC) on cardiovascular function, subjective effects, and performance in healthy adults. Kollins SH; Schoenfelder EN; English JS; Holdaway A; Van Voorhees E; O'Brien BR; Dew R; Chrisman AK J Subst Abuse Treat; 2015 Jan; 48(1):96-103. PubMed ID: 25175495 [TBL] [Abstract][Full Text] [Related]
16. Δ Doss MK; Weafer J; Gallo DA; de Wit H Biol Psychiatry; 2018 Nov; 84(10):743-750. PubMed ID: 29884456 [TBL] [Abstract][Full Text] [Related]
17. Marijuana withdrawal in humans: effects of oral THC or divalproex. Haney M; Hart CL; Vosburg SK; Nasser J; Bennett A; Zubaran C; Foltin RW Neuropsychopharmacology; 2004 Jan; 29(1):158-70. PubMed ID: 14560320 [TBL] [Abstract][Full Text] [Related]
18. Vaporized D-limonene selectively mitigates the acute anxiogenic effects of Δ9-tetrahydrocannabinol in healthy adults who intermittently use cannabis. Spindle TR; Zamarripa CA; Russo E; Pollak L; Bigelow G; Ward AM; Tompson B; Sempio C; Shokati T; Klawitter J; Christians U; Vandrey R Drug Alcohol Depend; 2024 Apr; 257():111267. PubMed ID: 38498958 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of divided attention psychophysical task performance and effects on pupil sizes following smoked, vaporized and oral cannabis administration. Newmeyer MN; Swortwood MJ; Taylor ME; Abulseoud OA; Woodward TH; Huestis MA J Appl Toxicol; 2017 Aug; 37(8):922-932. PubMed ID: 28138971 [TBL] [Abstract][Full Text] [Related]
20. Acute effects of THC on time perception in frequent and infrequent cannabis users. Sewell RA; Schnakenberg A; Elander J; Radhakrishnan R; Williams A; Skosnik PD; Pittman B; Ranganathan M; D'Souza DC Psychopharmacology (Berl); 2013 Mar; 226(2):401-13. PubMed ID: 23179965 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]